Investec Structured Products Calculus VCT plc
Issue of Equity
The Directors of Investec Structured Products Calculus VCT plc are pleased to
announce an allotment on 5 April 2011 of 187,679 C ordinary shares of 1p each
("C Shares") at an issue price of 100p per share, pursuant to the offer for
subscription that opened on 7 January 2011 ("Offer"). Applications for the
2011/2012 tax year will continue to be accepted until 12 noon 30 April 2011
(unless the Offer is fully subscribed prior to this date or extended at the
Directors absolute discretion).
Application for the C Shares to be admitted to the Official List of the UK
Listing Authority and to trading on the London Stock Exchange's main market
for listed securities has been made and it is expected that admission will
take place on 7 April 2011.
Following this allotment, there are now 1,832,505 C shares in issue.
For further enquiries please contact:
Gary Dale (Investec Structured Products)
Tel: 020 7597 4065
Email: gary.dale@investec.co.uk
Susan McDonald (Calculus Capital)
Tel: 0207 493 4940
Email: info@calculuscapital.com
6 April 2011
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.